What to Expect in 2025 and Beyond Todays GLP-1s are just the beginning of a major future factor influencing American health: behavior-supporting medication is in a renaissance, and investment in new medications and new indications is soaring
Viviani S, Negretti E, Orazi A, Sozzi G, Santoro A, Lissoni P,
The introduction of GLP-1 drugs in pill form is unlikely to reduce the cost of such medication but it will make it much easier for patients to take (Kolata, Robbins)
The aging astrocyte transcript .ome from multiple regions of the mouse brain
Oral capsules, powder, and transdermal/DMSO preparations are all in community use, with ongoing debate about absorption
The next era of obesity care is not about choosing between GLP-1s, surgery or lifestyle interventions